← TrialMatch
HomeTrials

A Game-based Neurodevelopmental Assessment for Young Children

The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their per

Condition(s)Neurodevelopmental Disorders, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Dyslexia, Specific Learning Disorder, Child Development
StatusRecruiting
Study typeObservational
SummaryThe aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool. The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All participants will complete the tablet game-based assessment which aims to assess a range of neuropsycholo
Who can participateInclusion Criteria: * 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder. OR * 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment. Exclusion Criteria: * Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.
Ages3 Years to 8 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorBrightlobe Limited
LocationsLondon, United Kingdom
Start date2023-01-30
NCT IDNCT05780853
Official listinghttps://clinicaltrials.gov/study/NCT05780853

🔍 Search all trials →